Schwere Sepsis im Kindesalter am Beispiel des Waterhouse-Friderichsen-Syndroms

Krueger M, Fluegge K, Krause MF, Berner R (2004) Fatal Haemophilus influenzae type b sepsis in a 10-month-old infant despite complete vaccination and adequate Hib antibodies. Eur J Pediatr 163:412–413

http://www.uniklinik-reiburg.de/kinderklinik/live/forschung/meningokokken/was.html

Bloos F, Bauer M, Reinhart K (2007) Pathopysiologie der Sepsis und des Multiorganversagens. In: Van Aken H, Reinhart K, Zimpfer M, Welte T (Hrsg) Intensivmedizin. Thieme, Stuttgart, S 831–842

Booy R, Habibi P, Nadel S et al (2001) Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 85:386–390

Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377

Lundberg JS, Perl TM, Wiblin D et al (1998) Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26:1020–1024

Vincent JL, Gerlach H (2004) Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32:451–454

Dellinger RP, Carlet JM, Masur H et al (2004) Surviving sepsis campaign management of severe sepsis and septic shock. Crit Care Med 32:858–873

Carcillo JA, Davis AL, Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266:1242–1245

Dula DJ, Lutz P, Weaver BN (1985) Rapid flow rates for the resuscitation of hypovolemic shock. Ann Emerg Med 14:303–306

Pollard AJ, Britto J, Nadel S et al (1999) Emergency management of meningococcal disease. Arch Dis Child 80:290–296

Reinhart K, Brunkhorst FK (2007) S2-Leitlinie: Diagnose und Therapie der Sepsis. Thieme, Stuttgart

Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

Laterre PF, Wittebole X (2003) Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification. Crit Care 7:445–450